Ejemplo: Heart Attack

Ensayos clínicos sobre Carcinosarcoma

Total 91 resultados

NCT03206177

Reclutamiento

Paclitaxel/Carboplatin + Galunisertib for Patients With Carcinosarcoma of the Uterus or Ovary

Condiciones: Carcinosarcoma, Ovarian
NCT02993705

Activo, no reclutando

Trial On Trabectedin In The Treatment Of Advanced Uterine And Ovarian Carcinosarcoma (CS)

Condiciones: Carcinosarcoma, Ovarian; Carcinosarcomas Uterine
NCT03651206

Reclutamiento

Recurrent Ovarian CarcinoSarcoma Anti-pd-1 Niraparib

Condiciones: Ovarian Carcinosarcoma; Endometrial Carcinosarcoma
NCT00687687

Completado

Evaluation of Paclitaxel (Taxol, NSC #673089), Carboplatin (Paraplatin, NSC #241240), and BSI-201 (NSC #746045, IND #71,677) in the Treatment of Advanced, Persistent, or Recurrent Uterine Carcinosarcoma

Condiciones: Uterine Carcinosarcoma
NCT04149275

Aún no reclutando

Cabozantinib Plus Nivolumab and Ipilimumab in Women With Recurrent Gynecologic Carcinosarcoma

Condiciones: Carcinosarcoma of Ovary; Carcinosarcoma of Uterus; Carcinosarcoma of Vagina
NCT04106414

Reclutamiento

Study of BMS-986205 and Nivolumab in Endometrial Cancer or Endometrial Carcinosarcoma That Has Not Responded to Treatment

Condiciones: Endometrial Adenocarcinoma; Endometrial Carcinosarcoma
NCT02203760

Reclutamiento

Pazopanib vs. Pazopanib Plus Gemcitabine

Condiciones: Leiomyosarcoma or Carcinosarcoma
NCT03933761

Reclutamiento

Pamiparib in Fusion Positive, Reversion Negative High Grade Serous Ovarian Cancer or Carcinosarcoma With BRCA1/2 Gene Mutations If Progression on Substrate Poly ADP Ribose Polymerase Inhibitbor (PARPI) or Chemotherapy

Condiciones: Ovarian Cancer; Carcinosarcoma
NCT00025506

Completado

Thalidomide in Treating Patients With Recurrent or Persistent Carcinosarcoma of the Uterus

Condiciones: Recurrent Uterine Corpus Sarcoma; Uterine Carcinosarcoma
NCT04513665

Reclutamiento

ZW25 in Women With Endometrial Cancers

Condiciones: Endometrial Cancer; Carcinosarcoma
NCT00502203

Completado

Paclitaxel and Carboplatin in Women With Malignant Mixed Mullerian Tumors (MMMT) of the Uterus

Condiciones: Mixed Tumor, Mullerian
NCT01247571

Completado

Pazopanib Hydrochloride in Treating Patients With Recurrent or Persistent Uterine Cancer

Condiciones: Recurrent Uterine Corpus Sarcoma; Uterine Carcinosarcoma
NCT01168232

Completado

Ixabepilone in Treating Patients With Recurrent or Persistent Uterine Cancer

Condiciones: Recurrent Uterine Corpus Sarcoma; Uterine Carcinosarcoma
NCT01061606

Terminado

Temsirolimus in Treating Patients With Recurrent or Persistent Cancer of the Uterus

Condiciones: Recurrent Uterine Sarcoma; Uterine Carcinosarcoma
NCT00476086

Completado

Oxaliplatin and Gemcitabine Followed by Radiation Therapy in the Management of Mixed Mullerian Tumors of the Uterus

Condiciones: Mixed Mullerian Tumors of the Uterus
NCT00114218

Completado

Gemcitabine and Docetaxel in Treating Patients With Recurrent or Persistent Uterine Cancer

Condiciones: Recurrent Uterine Corpus Sarcoma; Uterine Carcinosarcoma
NCT02964351

Estado desconocido

microRNA Profiles Identification in Adeno Carcinoma Prostate Cancer

Condiciones: Prostate Carcinosarcoma
NCT00075400

Completado

Imatinib Mesylate in Treating Patients With Recurrent or Persistent Uterine Cancer

Condiciones: Recurrent Uterine Sarcoma; Uterine Carcinosarcoma
NCT03395080

Activo, no reclutando

A Study of DKN-01 as a Monotherapy or in Combination With Paclitaxel in Patients With Recurrent Epithelial Endometrial or Epithelial Ovarian Cancer or Carcinosarcoma

Condiciones: Endometrial Cancer; Uterine Cancer; Ovarian Cancer; Carcinosarcoma
NCT01991808

Completado

Suitability of DCE-MRI for Detection of Vascular Changes After VBT

Condiciones: Carcinoma of the Cervix, Carcinoma or Carcinosarcoma of the Uterus
NCT03570437

Reclutamiento

Does Cediranib With Paclitaxel, or Cediranib and Olaparib, Treat Advanced Endometrial Cancer Better Than Paclitaxel?

Condiciones: Carcinosarcoma; Endometrial Neoplasms
NCT03668340

Reclutamiento

AZD1775 in Women With Recurrent or Persistent Uterine Serous Carcinoma or Uterine Carcinosarcoma

Condiciones: Uterine Cancer
NCT03648489

Reclutamiento

Dual mTorc Inhibition in advanCed/Recurrent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer (of Clear Cell, Endometrioid and High Grade Serous Type, and Carcinosarcoma)

Condiciones: Ovarian Cancer; Ovarian Neoplasms; Ovarian Carcinosarcoma; Ovarian Serous Adenocarcinoma; Ovarian Endometrioid Adenocarcinoma; Ovarian Clear Cell Adenocarcinoma; Fallopian Tube Cancer; Fallopian Tube Neoplasms; Primary Peritoneal Carcinoma; Primary Peritoneal Serous Adenocarcinoma
NCT03694262

Reclutamiento

The EndoBARR Trial (Endometrial Bevacizumab, Atezolizumab, Rucaparib)

Condiciones: Endometrial Cancer; Uterine Carcinosarcoma
NCT01454479

Estado desconocido

A Phase I Study of Lapatinib (Tykerb) Plus Ixabepilone (Ixempra) as 2nd-line Treatment for Patients With HER-2 Overexpressed Recurrent or Persistent Endometrial Carcinoma or Carcinosarcoma

Condiciones: Recurrent Endometrial Cancer